(Photo Credits: Rawpixel.com from Shutterstock)
A Norwegian man has entered long-term remission from HIV following a groundbreaking stem cell transplant from his own brother, marking a rare and significant development in decades-long efforts to eliminate the virus.
Now 63, the man, referred to as the “Oslo patient,” had been living with HIV since 2006. More than a decade later, in 2017, he was diagnosed with myelodysplastic syndrome, a rare and serious blood cancer that required a bone marrow transplant. With no ideal donor available, doctors ultimately turned to his older brother as the best option.
According to the doctors, this case is particularly notable because the donor happened to carry a rare genetic mutation known as CCR5. This mutation—which prevents HIV from entering immune cells, effectively blocking the virus from replicating—is present in only about one percent of people in Northern Europe and has been central to every known case of HIV remission linked to stem cell transplants.
“We had no idea… That was amazing,” said Dr. Anders Eivind Myhre of Oslo University Hospital, who led the research. The patient himself described the outcome as “it was like winning the lottery twice,” reflecting both the rarity of the genetic match and the success of the treatment.
The transplant, performed in 2020, replaced the patient’s immune system with that of his brother. Over time, the newly formed immune cells—resistant to HIV—took over completely. Two years later, doctors discontinued his antiretroviral therapy, closely monitoring for any return of the virus.
So far, none has been detected. Extensive testing of his blood, gut, and bone marrow has shown no trace of HIV. “For all practical purposes, we are quite certain that he is cured,” Myhre said.
According to his medical team, the patient has since regained strong health and vitality. He is described as “having a great time” and enjoying life with renewed energy, a stark contrast to the years spent managing both HIV and a life-threatening cancer diagnosis.
Researchers note that this case stands out because the donor was a close family member. It is the first documented instance in which a sibling transplant has led to this level of HIV remission. The patient’s immune system had been “completely replaced” by the donor’s, according to study co-author Marius Trøseid of the University of Oslo—an outcome confirmed through analysis of multiple tissues.
“The Oslo patient is perhaps no longer a patient. At least he doesn’t feel like it,” Trøseid said.
This case adds to a growing, though still extremely limited, group of similar outcomes. The first widely recognized instance involved Timothy Ray Brown, who underwent a comparable transplant in 2008 and became the first person declared cured of HIV/AIDS. Since then, a handful of patients in cities such as London, New York, Geneva, and Düsseldorf have experienced long-term remission under similar conditions.
While these cases offer hope, experts emphasize that stem cell transplants remain high-risk procedures, typically reserved for patients already facing life-threatening cancers. As such, they are not a viable solution for the broader population living with HIV.
Instead, scientists are focusing on what these rare successes reveal. By studying how the virus is eliminated in such cases, researchers aim to develop safer, more accessible treatments, potentially through gene-editing technologies or therapies that replicate the protective effect of the CCR5 mutation.
For now, the Oslo patient’s story represents both progress and possibility, a reminder that while an HIV cure remains complex, it is no longer beyond reach. Read here for more information about this story.
Awesome, KEEP WORKING on a cure and vaccine against this virus!
It’s so wonderful to see other countries investing in health and science. Please save us!
It’d be great to totally irradicate this virus.
Maybe then they would focus on the other diseases that plague our community but get NO support or treatment, Chronic Fatigue Syndrome and Fibromyalgia. Because they mostly affect women and gay men, no one cares.
Chronic Fatigue Syndrome is not a gay disease. HIV/AIDS has decimated our community. It’s also an adversity that we had to take on because a certain branch of our government refused to assist. You should research an gentleman named Larry Kramer.
You don’t understand. There is no real interest in the biotech community to make a vaccine for HIV. They make more money selling the antiretroviral and PrEP drugs than they ever will on a vaccine. There just isn’t a big interest in it outside of some educational institutions. This procedure in the article is a one off and needs a lot of things to be in play for it to even work. I would also suspect that it is also VERY expensive to do. The guy who had his HIV cured went through a lot of pain when they zapped… Read more »
How do you know, what I don’t understand; I understand, that most conditions are not to be cured, but rather profited from; curing the symptoms only, rather than the causation of said symptoms. This is what find frustrating about the “Pharmaceuticals.”
Agree. Been around much to long.
This is AMAZING News! I honestly believe in 10/20 years this could lead to a cure for HIV virus!!!
They had no idea??? There have always been some people who have a natural resistance to HIV, and I’m sure at least some of them have been studied. Perhaps that’s how they knew about the mutation.
I think people who have this genetic mutation can have HIV in their system, it just never progresses to AIDS. Not sure if they are able to transmit it to others though.
Has everything to do with the plague during the Middle Ages. Those that it didn’t kill, developed immunities, that they passed on to other generations.
He can get HIV again now
Yeah the only problem is that after any type of transplant, you are on immunosuppressive drugs for life, which makes you vulnerable to common opportunistic infections.
He’s not on immunosuppressants because his immune system was replaced by his brother’s. Thankfully for him, their genetics are similar enough that his new immune system doesn’t attack his pre-transplant cells. You’re right about the immunosuppressants in most cases of non-autologous transplants, though.